Evolutionary Study on the Y Chromosome: A Comprehensive Review

Introduction: The Y chromosome, essential for male sex determination and reproduction, has undergone significant evolutionary shrinkage, losing most of its genetic content. This review explores the biological and historical significance of the Y chromosome, its role in male-specific traits, spermatogenesis, and secondary sexual characteristics. It also examines the implications of its shrinking for male infertility, cancer risk, and aging-related diseases, along with potential pharmacological and genetic solutions Method: A comprehensive review of existing literature, cross-species studies, and recent advancements in genetics and medical research was conducted. Based on mechanisms of Y chromosome degeneration, its impact on health, and possible therapeutic interventions, including hormone replacement therapies, assisted reproductive technologies, and geneediting techniques like CRISPR. Results: Despite reducing from 1,400 to 55 active genes, the Y chromosome retains key functions in testosterone production and sperm maturation through genes like SRY, DAZ, and TSPY. Studies suggest alternative mechanisms for male traits in the absence of the Y chromosome, raising questions about its future in humans. Discussion: The shrinkage is linked to infertility, increased cancer risk, and aging-related disorders. Potential pharmacological approaches involve hormone replacement therapies, assisted reproductive technologies, and gene-editing techniques like CRISPR. Conclusion: The shrinking Y chromosome poses challenges to male health, but scientific advancements offer hope for mitigating its effects. Integrating genetic research, evolutionary studies, and medical innovations is crucial for addressing Y-linked disorders and guiding the future of male health and reproduction.

Authors

Institutions

Publication Details

Journal
Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine
Published
2026-01-22
DOI
https://doi.org/10.2174/0118756921389203251118065730
Primary Topic
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evolutionary Study on the Y Chromosome: A Comprehensive Review

Krishna Chandra Panda, Bimalendu Chowdhury, Nitish Sahu, Sanjiv Kumar Panda et al.
Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
article

Evolutionary Study on the Y Chromosome: A Comprehensive Review

Krishna Chandra Panda, Bimalendu Chowdhury, Nitish Sahu, Sanjiv Kumar Panda, Ansuman Sahu
article en

Abstract

Introduction: The Y chromosome, essential for male sex determination and reproduction, has undergone significant evolutionary shrinkage, losing most of its genetic content. This review explores the biological and historical significance of the Y chromosome, its role in male-specific traits, spermatogenesis, and secondary sexual characteristics. It also examines the implications of its shrinking for male infertility, cancer risk, and aging-related diseases, along with potential pharmacological and genetic solutions Method: A comprehensive review of existing literature, cross-species studies, and recent advancements in genetics and medical research was conducted. Based on mechanisms of Y chromosome degeneration, its impact on health, and possible therapeutic interventions, including hormone replacement therapies, assisted reproductive technologies, and geneediting techniques like CRISPR. Results: Despite reducing from 1,400 to 55 active genes, the Y chromosome retains key functions in testosterone production and sperm maturation through genes like SRY, DAZ, and TSPY. Studies suggest alternative mechanisms for male traits in the absence of the Y chromosome, raising questions about its future in humans. Discussion: The shrinkage is linked to infertility, increased cancer risk, and aging-related disorders. Potential pharmacological approaches involve hormone replacement therapies, assisted reproductive technologies, and gene-editing techniques like CRISPR. Conclusion: The shrinking Y chromosome poses challenges to male health, but scientific advancements offer hope for mitigating its effects. Integrating genetic research, evolutionary studies, and medical innovations is crucial for addressing Y-linked disorders and guiding the future of male health and reproduction.

Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicineVol. 23
Roland Institute of Pharmaceutical Sciences (IN)
Gender equality
Openalex Percentile: Top 67%
Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.